How nuclear imaging changed parathyroid surgical strategies through time

Ver Detalles

Molecular Imaging in Gynecology: Beyond Cancer

Ver Detalles

Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy

Ver Detalles

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics

Ver Detalles

Production and regulatory issues for theranostics

Ver Detalles

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

Ver Detalles

Systematic Review of the First 40 Cases of 177Lu-PSMA Therapy in the Treatment of Non-prostatic Cancer

Ver Detalles

Is 161Tb Really Happening?

Ver Detalles

Granzyme B PET Imaging for Assessment of Disease Activity in Inflammatory Bowel Disease

Ver Detalles

Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?

Ver Detalles

Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses

Ver Detalles

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Ver Detalles

99mTc‑labeled FAPI compounds for cancer and infammation: from radiochemistry to the first clinical applications

Ver Detalles

Desarrollo y validación de un procedimiento alternativo para realizar los controles de pureza radioquímica de radiofármacos de 99mTc con un contador Geiger Müller

Ver Detalles

First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer

Ver Detalles

Risk Management in Good Manufacturing Practice (GMP) Radiopharmaceutical Preparations

Ver Detalles
Scroll al inicio